Better Med Spa

Medications offered

As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.

• Compounded tirzepatide microdose (sublingual drops or injectable)Compounded · not FDA-approved

What they publish

Better Med Spa publishes 2 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers

Membership / programme fee

$300 per month on three-month treatment plans, with a $200/month three-month plan option also published (as published)

Medication cost

Not publicly disclosed on the pages we captured.

Introductory offer

Not publicly disclosed on the pages we captured.

Insurance

Not publicly disclosed on the pages we captured.

HSA / FSA

Not publicly disclosed on the pages we captured.

Consultation process

Not publicly disclosed on the pages we captured.

Eligibility

Chicago, Lincoln Park based.

Lab work

Not publicly disclosed on the pages we captured.

Pharmacy fulfilment

Not publicly disclosed on the pages we captured.

Shipping

Not publicly disclosed on the pages we captured.

Support services

Not publicly disclosed on the pages we captured.

Cancellation

Not publicly disclosed on the pages we captured.

Refunds

Not publicly disclosed on the pages we captured.

What stands out

• Offers sublingual drops as well as injection. Sublingual GLP-1 formulations are further from the studied products than compounded injectables, and their absorption is not established the same way.
• Microdosing is not an FDA-approved regimen.
• Sold in three-month plans, so the commitment is roughly $600–$900.

Questions to ask before you pay

These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.

• Ask what evidence supports sublingual delivery specifically, and discuss it with a clinician who is not selling it.
• Three-month plans — ask what happens if you stop early.
• Ask which pharmacy compounds the product and whether it is 503A or 503B.